Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-10-09
1987-04-07
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 7, 514 9, 514213, 514221, 514250, 514259, 514310, 514419, 514490, 514562, 514912, A61K 31195, A61K 3140, A61K 3127, A61K 31505
Patent
active
046561889
ABSTRACT:
Angiotensin converting enzyme inhibitors are useful in the treatment of senile macular degeneration.
REFERENCES:
patent: 3995057 (1976-11-01), Horrmann
patent: 4046889 (1977-09-01), Ondetti et al.
Igic and Kojovic, Exp. Eye Res., 30, 299-303 (1980).
Chem. Abst. 74:91148w (1971)--Dabis.
Chem. Abst. 96:210615n (1982)--Toshimoto et al.
Chem. Abst. 99:47727b (1983)--Yamagami et al.
Chem. Abst. 101:177530c (1984)--Watkins et al.
Baldwin John J.
Veber Daniel F.
Merck & Co. , Inc.
Nicholson William H.
Robinson Douglas W.
Sudol Michael C.
LandOfFree
Ace inhibitors in macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ace inhibitors in macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ace inhibitors in macular degeneration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1087128